We're excited to reveal the Specialty Chief Editors' top Research Topic picks for 2025 for Frontiers in Immunology.
The following Research Topics will be led by experts in their field and contribute to the scientific understanding of Immunology. These Research topics will be published in the peer-reviewed journal Frontiers in Immunology, as open access articles.
Frontiers' Research Topics are peer-reviewed article collections around cutting-edge research themes.
Learn more about how these Research topics work. Want to contribute to one of these topics? Just email us at immunology@frontiersin.org and we'll be in touch. The below are topics scheduled for 2025 for this specialty section:
Final list to be announced
Modulating B Cell Subsets: Future Therapeutics for Autoimmune Diseases - led by Chris Wincup, Peter Korsten & Mariele Gatto
Insights into the Diagnosis, Pathogenesis and Management of Takayasu Arteritis - led by Durga Prasanna Misra, Corrado Campochiaro, Fatma Alibaz-Oner & Alessandro Tomelleri
Early Diagnosis and Intervention in Psoriatic Arthritis: Unraveling Clinical and Immunoinflammatory Mysteries - led by Piero Ruscitti, Raffaele Scarpa & Francesco Caso
Spotlight on Emerging Research: Innovation Perspectives in Autoimmune Disease Investigation
Evolution of Theories in Autoimmune Disease: From Early Concepts to Modern Integrations - Gunnar Houen & Nicole Trier
Chemokine Pathway Targeting for Type 1 Diabetes: Unraveling Therapeutic Efficacy and Challenges - Urs Christen
Pathogenic Mechanisms and Genetic Architecture: Biomarker-Driven Insights into Autoimmune Diseases
Emerging Therapeutics in Autoimmunity: From early-stage strategies to clinical application
Epigenetic Profiling and Computational Modelling in Autoimmune Disease Research
Overcoming Scientific Hurdles: Current Challenges and Future Directions in Autoimmune Research
Spotlight on Emerging Research: Innovation Perspectives in Autoimmune Disease Investigation
Want to contribute? Just email us at immunology@frontiersin.org and we'll be in touch.